A detailed history of Schonfeld Strategic Advisors LLC transactions in Optimize Rx Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 61,648 shares of OPRX stock, worth $935,816. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61,648
Previous 243,643 74.7%
Holding current value
$935,816
Previous $3.29 Million 61.6%
% of portfolio
0.01%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$12.48 - $20.51 $2.27 Million - $3.73 Million
-181,995 Reduced 74.7%
61,648 $1.26 Million
Q2 2025

Aug 14, 2025

BUY
$7.44 - $15.44 $904,845 - $1.88 Million
121,619 Added 99.67%
243,643 $3.29 Million
Q1 2025

May 15, 2025

BUY
$4.14 - $9.47 $505,179 - $1.16 Million
122,024 New
122,024 $1.06 Million
Q1 2022

May 16, 2022

SELL
$35.27 - $62.91 $214,194 - $382,052
-6,073 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$53.57 - $98.0 $325,330 - $595,154
6,073 New
6,073 $378,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $274M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.